Form: 3

Initial statement of beneficial ownership of securities

May 2, 2011

FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  DVONCH JEROME J
 2. Date of Event Requiring Statement (Month/Day/Year)
05/02/2011		 3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [NGNM.OB]
(Last)
(First)
(Middle)
C/O NEOGENOMICS, INC., 12701 COMMONWEALTH DRIVE SUITE 9		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Prinicpal Accounting Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

FORT MYERS, FL US 33913		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) 07/28/2005 07/27/2015 Common Stock 17,500 $ 0.37 D  
Stock Option (right to buy) 09/15/2007 09/14/2016 Common Stock 35,000 $ 1 D  
Stock Option (right to buy) 02/13/2007 02/12/2017 Common Stock 19,167 $ 1.47 D  
Stock Option (right to buy) 03/15/2007 03/14/2017 Common Stock 50,000 $ 1.49 D  
Stock Option (right to buy) 07/01/2008(1) 07/01/2015 Common Stock 74,000 $ 1.04 D  
Stock Option (right to buy) 12/31/2009(2) 02/02/2016 Common Stock 19,500 $ 0.62 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
DVONCH JEROME J
C/O NEOGENOMICS, INC.
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS, FL US 33913		       Prinicpal Accounting Officer  

Signatures

/s/ Jerome J Dvonch 05/02/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On July 1, 2008 Mr. Dvonch was granted options to purchase 100,000 shares. These were a combination of monthly time based vesting over forty eight months and performance based options. The first exercisable date was July 1, 2008. To date 26,000 shares have been cancelled, 53,500 shares are vested and 20,500 shares are unvested.
(2) On February 2, 2009 Mr. Dvonch was granted options to purchase 26,000 shares with performance based vesting. The first date options became exercisable was December 31, 2009. To date 13,000 shares are exercisable and 6,500 shares have been cancelled. There are 6,500 unvested and non-exercisable options.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.